2 mg retatrutide Understanding the starting dose ESC 2024: Retatrutide improves lipid

Pregnant or breastfeeding individuals should also not use it

GLP-1 adoption more than doubled over the same period, from 5.8 to 12.4 percent of American adults

doi: 10.1152/ajprenal.00174.2007 90 Carraro-LacroixLRMalnicGGirardiAC

Retatrutide, also known as LY-3437943 or triple G is an investigational multi-agonist peptide studied for its activity at GLP-1, GIP and glucagon receptors

Make sure theres a way to get a quick response from a licensed practitioner (ideally someone trained in obesity medicine) if you dont feel well or have questions, like by messaging through a patient portal

Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credits: Canva Itisha Arya Updated Dec 18, 2025 | 09:00 PM IST Summary Retatrutide is drawing attention after new trial data showed dramatic weight loss and pain relief